General discussion, page-235

This drop in price is purely due to a poor communication strategy from management, the fundamentals of the stock look reasonable, especially with the boost to cashflow we'll see once health house international merge with us. The crew at Morningstar seem to think the stock is significantly undervalued.

I suspect this will come around in the medium to long term, but we're in for short term pain while we wait on market sentiment to swing positive. Cool heads required or losses will be locked in due to selling. For those who may be concerned about quarterly cash burn, Zelira isn't unique in this area, check out the latest report from little green pharma, yet market sentiment is positive in general for that organisation. Why? Because the management team are excellent communicators and understand marketing.